Where I see patients (3)
My reviews
4.9
Selected research
-
Prospective genomically-guided identification of 'early/evolving' and 'undersampled' IDH-wildtype glioblastoma leads to improved clinical outcomes.
Neuro-oncology
-
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications.
Neuro-oncology
-
Sarcopenia diagnosed using masseter muscle diameter as a survival correlate in elderly patients with glioblastoma.
World neurosurgery